SIRT3 Deacetylates and Activates OPA1 To Regulate Mitochondrial Dynamics during Stress

REFERENCES

• Bell EL, Guarente L. 2011. The SirT3 divining rod points to oxidative stress. Mol. Cell 42:561–568. http://dx.doi.org/10.1016/j.molcel.2011.05.008.
   PubMed Web of Science ®Google Scholar
• He W, Newman JC, Wang MZ, Ho L, Verdin E. 2012. Mitochondrial sirtuins: regulators of protein acylation and metabolism. Trends Endocrinol. Metab. 23:467–476. http://dx.doi.org/10.1016/j.tem.2012.07.004.
   PubMed Web of Science ®Google Scholar
• Lombard DB, Alt FW, Cheng HL, Bunkenborg J, Streeper RS, Mostoslavsky R, Kim J, Yancopoulos G, Valenzuela D, Murphy A, Yang Y, Chen Y, Hirschey MD, Bronson RT, Haigis M, Guarente LP, Farese RVJr, Weissman S, Verdin E, Schwer B. 2007. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol. Cell. Biol. 27:8807–8814. http://dx.doi.org/10.1128/MCB.01636-07.
   PubMed Web of Science ®Google Scholar
• Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage J, Owens KM, Vassilopoulos A, Ozden O, Park SH, Singh KK, Abdulkadir SA, Spitz DR, Deng CX, Gius D. 2010. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 17:41–52. http://dx.doi.org/10.1016/j.ccr.2009.11.023.
   PubMed Web of Science ®Google Scholar
• Someya S, Yu W, Hallows WC, Xu J, Vann JM, Leeuwenburgh C, Tanokura M, Denu JM, Prolla TA. 2010. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143:802–812. http://dx.doi.org/10.1016/j.cell.2010.10.002.
   PubMed Web of Science ®Google Scholar
• Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A, Gupta MP. 2009. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J. Clin. Invest. 119:2758–2771. http://dx.doi.org/10.1172/JCI39162.
   PubMed Web of Science ®Google Scholar
• Caton PW, Richardson SJ, Kieswich J, Bugliani M, Holland ML, Marchetti P, Morgan NG, Yaqoob MM, Holness MJ, Sugden MC. 2013. Sirtuin 3 regulates mouse pancreatic beta cell function and is suppressed in pancreatic islets isolated from human type 2 diabetic patients. Diabetologia 56:1068–1077. http://dx.doi.org/10.1007/s00125-013-2851-y.
   PubMed Web of Science ®Google Scholar
• Bellizzi D, Rose G, Cavalcante P, Covello G, Dato S, De Rango F, Greco V, Maggiolini M, Feraco E, Mari V, Franceschi C, Passarino G, De Benedictis G. 2005. A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 85:258–263. http://dx.doi.org/10.1016/j.ygeno.2004.11.003.
   PubMed Web of Science ®Google Scholar
• Rose G, Dato S, Altomare K, Bellizzi D, Garasto S, Greco V, Passarino G, Feraco E, Mari V, Barbi C, BonaFe M, Franceschi C, Tan Q, Boiko S, Yashin AI, De Benedictis G. 2003. Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly. Exp. Gerontol. 38:1065–1070. http://dx.doi.org/10.1016/S0531-5565(03)00209-2.
   PubMed Web of Science ®Google Scholar
• Chan DC. 2006. Mitochondrial fusion and fission in mammals. Annu. Rev. Cell Dev. Biol. 22:79–99. http://dx.doi.org/10.1146/annurev.cellbio.22.010305.104638.
   PubMed Web of Science ®Google Scholar
• Liesa M, Palacin M, Zorzano A. 2009. Mitochondrial dynamics in mammalian health and disease. Physiol. Rev. 89:799–845. http://dx.doi.org/10.1152/physrev.00030.2008.
   PubMed Web of Science ®Google Scholar
• Westermann B. 2010. Mitochondrial fusion and fission in cell life and death. Nat. Rev. Mol. Cell Biol. 11:872–884. http://dx.doi.org/10.1038/nrm3013.
   PubMed Web of Science ®Google Scholar
• Chen H, Chomyn A, Chan DC. 2005. Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J. Biol. Chem. 280:26185–26192. http://dx.doi.org/10.1074/jbc.M503062200.
   PubMed Web of Science ®Google Scholar
• Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC. 2003. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J. Cell Biol. 160:189–200. http://dx.doi.org/10.1083/jcb.200211046.
   PubMed Web of Science ®Google Scholar
• Cipolat S, Martins de Brito O, Dal Zilio B, Scorrano L. 2004. OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc. Natl. Acad. Sci. U. S. A. 101:15927–15932. http://dx.doi.org/10.1073/pnas.0407043101.
   PubMed Web of Science ®Google Scholar
• Smirnova E, Griparic L, Shurland DL, van der Bliek AM. 2001. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol. Biol. Cell 12:2245–2256. http://dx.doi.org/10.1091/mbc.12.8.2245.
   PubMed Web of Science ®Google Scholar
• Yoon Y, Krueger EW, Oswald BJ, McNiven MA. 2003. The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like protein DLP1. Mol. Cell. Biol. 23:5409–5420. http://dx.doi.org/10.1128/MCB.23.15.5409-5420.2003.
   PubMed Web of Science ®Google Scholar
• Zhao J, Lendahl U, Nister M. 2013. Regulation of mitochondrial dynamics: convergences and divergences between yeast and vertebrates. Cell. Mol. Life Sci. 70:951–976. http://dx.doi.org/10.1007/s00018-012-1066-6.
   PubMed Web of Science ®Google Scholar
• Kim SC, Sprung R, Chen Y, Xu Y, Ball H, Pei J, Cheng T, Kho Y, Xiao H, Xiao L, Grishin NV, White M, Yang XJ, Zhao Y. 2006. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 23:607–618. http://dx.doi.org/10.1016/j.molcel.2006.06.026.
   PubMed Web of Science ®Google Scholar
• Giralt A, Hondares E, Villena JA, Ribas F, Diaz-Delfin J, Giralt M, Iglesias R, Villarroya F. 2011. Peroxisome proliferator-activated receptor-gamma coactivator-1alpha controls transcription of the Sirt3 gene, an essential component of the thermogenic brown adipocyte phenotype. J. Biol. Chem. 286:16958–16966. http://dx.doi.org/10.1074/jbc.M110.202390.
   PubMed Web of Science ®Google Scholar
• Hirschey MD, Shimazu T, Jing E, Grueter CA, Collins AM, Aouizerat B, Stancakova A, Goetzman E, Lam MM, Schwer B, Stevens RD, Muehlbauer MJ, Kakar S, Bass NM, Kuusisto J, Laakso M, Alt FW, Newgard CB, Farese RVJr, Kahn CR, Verdin E. 2011. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol. Cell 44:177–190. http://dx.doi.org/10.1016/j.molcel.2011.07.019.
   PubMed Web of Science ®Google Scholar
• Kong X, Wang R, Xue Y, Liu X, Zhang H, Chen Y, Fang F, Chang Y. 2010. Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One 5:e11707. http://dx.doi.org/10.1371/journal.pone.0011707.
   PubMed Web of Science ®Google Scholar
• Frezza C, Cipolat S, Martins de Brito O, Micaroni M, Beznoussenko GV, Rudka T, Bartoli D, Polishuck RS, Danial NN, De Strooper B, Scorrano L. 2006. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126:177–189. http://dx.doi.org/10.1016/j.cell.2006.06.025.
   PubMed Web of Science ®Google Scholar
• Olichon A, Baricault L, Gas N, Guillou E, Valette A, Belenguer P, Lenaers G. 2003. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J. Biol. Chem. 278:7743–7746. http://dx.doi.org/10.1074/jbc.C200677200.
   PubMed Web of Science ®Google Scholar
• Belenguer P, Pellegrini L. 2013. The dynamin GTPase OPA1: more than mitochondria? Biochim. Biophys. Acta 1833:176–183. http://dx.doi.org/10.1016/j.bbamcr.2012.08.004.
   PubMed Web of Science ®Google Scholar
• Chen L, Gong Q, Stice JP, Knowlton AA. 2009. Mitochondrial OPA1, apoptosis, and heart failure. Cardiovasc. Res. 84:91–99. http://dx.doi.org/10.1093/cvr/cvp181.
   PubMed Web of Science ®Google Scholar
• Chen L, Liu T, Tran A, Lu X, Tomilov AA, Davies V, Cortopassi G, Chiamvimonvat N, Bers DM, Votruba M, Knowlton AA. 2012. OPA1 mutation and late-onset cardiomyopathy: mitochondrial dysfunction and mtDNA instability. J. Am. Heart Assoc. 1:e003012. http://dx.doi.org/10.1161/JAHA.112.003012.
   PubMedGoogle Scholar
• Piquereau J, Caffin F, Novotova M, Prola A, Garnier A, Mateo P, Fortin D, Huynh le H, Nicolas V, Alavi MV, Brenner C, Ventura-Clapier R, Veksler V, Joubert F. 2012. Down-regulation of OPA1 alters mouse mitochondrial morphology, PTP function, and cardiac adaptation to pressure overload. Cardiovasc. Res. 94:408–417. http://dx.doi.org/10.1093/cvr/cvs117.
   PubMed Web of Science ®Google Scholar
• Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M. 2009. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325:834–840. http://dx.doi.org/10.1126/science.1175371.
   PubMed Web of Science ®Google Scholar
• Sundaresan NR, Vasudevan P, Zhong L, Kim G, Samant S, Parekh V, Pillai VB, Ravindra PV, Gupta M, Jeevanandam V, Cunningham JM, Deng CX, Lombard DB, Mostoslavsky R, Gupta MP. 2012. The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun. Nat. Med. 18:1643–1650. http://dx.doi.org/10.1038/nm.2961.
   PubMed Web of Science ®Google Scholar
• Song Z, Ghochani M, McCaffery JM, Frey TG, Chan DC. 2009. Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. Mol. Biol. Cell 20:3525–3532. http://dx.doi.org/10.1091/mbc.E09-03-0252.
   PubMed Web of Science ®Google Scholar
• Davis FJ, Gupta M, Pogwizd SM, Bacha E, Jeevanandam V, Gupta MP. 2002. Increased expression of alternatively spliced dominant-negative isoform of SRF in human failing hearts. Am. J. Physiol. Heart Circ. Physiol. 282:H1521–H1533. http://dx.doi.org/10.1152/ajpheart.00844.2001.
   PubMedGoogle Scholar
• Finley LW, Carracedo A, Lee J, Souza A, Egia A, Zhang J, Teruya-Feldstein J, Moreira PI, Cardoso SM, Clish CB, Pandolfi PP, Haigis MC. 2011. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization. Cancer Cell 19:416–428. http://dx.doi.org/10.1016/j.ccr.2011.02.014.
   PubMed Web of Science ®Google Scholar
• Sundaresan NR, Samant SA, Pillai VB, Rajamohan SB, Gupta MP. 2008. SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70. Mol. Cell. Biol. 28:6384–6401. http://dx.doi.org/10.1128/MCB.00426-08.
   PubMed Web of Science ®Google Scholar
• Song Z, Chen H, Fiket M, Alexander C, Chan DC. 2007. OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. J. Cell Biol. 178:749–755. http://dx.doi.org/10.1083/jcb.200704110.
   PubMed Web of Science ®Google Scholar
• Ban T, Heymann JA, Song Z, Hinshaw JE, Chan DC. 2010. OPA1 disease alleles causing dominant optic atrophy have defects in cardiolipin-stimulated GTP hydrolysis and membrane tubulation. Hum. Mol. Genet. 19:2113–2122. http://dx.doi.org/10.1093/hmg/ddq088.
   PubMed Web of Science ®Google Scholar
• Samant SA, Courson DS, Sundaresan NR, Pillai VB, Tan M, Zhao Y, Shroff SG, Rock RS, Gupta MP. 2011. HDAC3-dependent reversible lysine acetylation of cardiac myosin heavy chain isoforms modulates their enzymatic and motor activity. J. Biol. Chem. 286:5567–5577. http://dx.doi.org/10.1074/jbc.M110.163865.
   PubMed Web of Science ®Google Scholar
• Karbowski M, Lee YJ, Gaume B, Jeong SY, Frank S, Nechushtan A, Santel A, Fuller M, Smith CL, Youle RJ. 2002. Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J. Cell Biol. 159:931–938. http://dx.doi.org/10.1083/jcb.200209124.
   PubMed Web of Science ®Google Scholar
• Choi SY, Huang P, Jenkins GM, Chan DC, Schiller J, Frohman MA. 2006. A common lipid links Mfn-mediated mitochondrial fusion and SNARE-regulated exocytosis. Nat. Cell Biol. 8:1255–1262. http://dx.doi.org/10.1038/ncb1487.
   PubMed Web of Science ®Google Scholar
• Marsboom G, Toth PT, Ryan JJ, Hong Z, Wu X, Fang YH, Thenappan T, Piao L, Zhang HJ, Pogoriler J, Chen Y, Morrow E, Weir EK, Rehman J, Archer SL. 2012. Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension. Circ. Res. 110:1484–1497. http://dx.doi.org/10.1161/CIRCRESAHA.111.263848.
   PubMed Web of Science ®Google Scholar
• Rehman J, Zhang HJ, Toth PT, Zhang Y, Marsboom G, Hong Z, Salgia R, Husain AN, Wietholt C, Archer SL. 2012. Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer. FASEB J. 26:2175–2186. http://dx.doi.org/10.1096/fj.11-196543.
   PubMed Web of Science ®Google Scholar
• Hafner AV, Dai J, Gomes AP, Xiao CY, Palmeira CM, Rosenzweig A, Sinclair DA. 2010. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging 2:914–923.
   PubMedGoogle Scholar
• Twig G, Elorza A, Molina AJ, Mohamed H, Wikstrom JD, Walzer G, Stiles L, Haigh SE, Katz S, Las G, Alroy J, Wu M, Py BF, Yuan J, Deeney JT, Corkey BE, Shirihai OS. 2008. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J. 27:433–446. http://dx.doi.org/10.1038/sj.emboj.7601963.
   PubMed Web of Science ®Google Scholar
• Bao J, Scott I, Lu Z, Pang L, Dimond CC, Gius D, Sack MN. 2010. SIRT3 is regulated by nutrient excess and modulates hepatic susceptibility to lipotoxicity. Free Radic. Biol. Med. 49:1230–1237. http://dx.doi.org/10.1016/j.freeradbiomed.2010.07.009.
   PubMed Web of Science ®Google Scholar
• Tang S, Le PK, Tse S, Wallace DC, Huang T. 2009. Heterozygous mutation of Opa1 in Drosophila shortens lifespan mediated through increased reactive oxygen species production. PLoS One 4:e4492. http://dx.doi.org/10.1371/journal.pone.0004492.
   PubMed Web of Science ®Google Scholar
• Akepati VR, Muller EC, Otto A, Strauss HM, Portwich M, Alexander C. 2008. Characterization of OPA1 isoforms isolated from mouse tissues. J. Neurochem. 106:372–383. http://dx.doi.org/10.1111/j.1471-4159.2008.05401.x.
   PubMedGoogle Scholar
• Jing E, Emanuelli B, Hirschey MD, Boucher J, Lee KY, Lombard D, Verdin EM, Kahn CR. 2011. Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production. Proc. Natl. Acad. Sci. U. S. A. 108:14608–14613. http://dx.doi.org/10.1073/pnas.1111308108.
   PubMed Web of Science ®Google Scholar
• Antonetti DA, Reynet C, Kahn CR. 1995. Increased expression of mitochondrial-encoded genes in skeletal muscle of humans with diabetes mellitus. J. Clin. Invest. 95:1383–1388. http://dx.doi.org/10.1172/JCI117790.
   PubMedGoogle Scholar
• Hsieh CJ, Weng SW, Liou CW, Lin TK, Chen JB, Tiao MM, Hung YT, Chen IY, Huang WT, Wang PW. 2011. Tissue-specific differences in mitochondrial DNA content in type 2 diabetes. Diabetes Res. Clin. Pract. 92:106–110. http://dx.doi.org/10.1016/j.diabres.2011.01.010.
   PubMedGoogle Scholar
• Amati-Bonneau P, Valentino ML, Reynier P, Gallardo ME, Bornstein B, Boissiere A, Campos Y, Rivera H, de la Aleja JG, Carroccia R, Iommarini L, Labauge P, Figarella-Branger D, Marcorelles P, Furby A, Beauvais K, Letournel F, Liguori R, La Morgia C, Montagna P, Liguori M, Zanna C, Rugolo M, Cossarizza A, Wissinger B, Verny C, Schwarzenbacher R, Martin MA, Arenas J, Ayuso C, Garesse R, Lenaers G, Bonneau D, Carelli V. 2008. OPA1 mutations induce mitochondrial DNA instability and optic atrophy ‘plus' phenotypes. Brain 131:338–351. http://dx.doi.org/10.1093/brain/awm298.
   PubMedGoogle Scholar
• Hudson G, Amati-Bonneau P, Blakely EL, Stewart JD, He L, Schaefer AM, Griffiths PG, Ahlqvist K, Suomalainen A, Reynier P, McFarland R, Turnbull DM, Chinnery PF, Taylor RW. 2008. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 131:329–337. http://dx.doi.org/10.1093/brain/awm272.
   PubMed Web of Science ®Google Scholar
• Kang YJ, Chen Y, Epstein PN. 1996. Suppression of doxorubicin cardiotoxicity by overexpression of catalase in the heart of transgenic mice. J. Biol. Chem. 271:12610–12616. http://dx.doi.org/10.1074/jbc.271.21.12610.
   PubMed Web of Science ®Google Scholar
• Singal PK, Iliskovic N. 1998. Doxorubicin-induced cardiomyopathy. N. Engl. J. Med. 339:900–905. http://dx.doi.org/10.1056/NEJM199809243391307.
   PubMed Web of Science ®Google Scholar
• Suliman HB, Carraway MS, Ali AS, Reynolds CM, Welty-Wolf KE, Piantadosi CA. 2007. The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. J. Clin. Invest. 117:3730–3741. http://dx.doi.org/10.1172/JCI32967.
   PubMed Web of Science ®Google Scholar
• Onyango P, Celic I, McCaffery JM, Boeke JD, Feinberg AP. 2002. SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria. Proc. Natl. Acad. Sci. U. S. A. 99:13653–13658. http://dx.doi.org/10.1073/pnas.222538099.
   PubMed Web of Science ®Google Scholar
• Shi T, Wang F, Stieren E, Tong Q. 2005. SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J. Biol. Chem. 280:13560–13567. http://dx.doi.org/10.1074/jbc.M414670200.
   PubMed Web of Science ®Google Scholar
• Park SH, Ozden O, Jiang H, Cha YI, Pennington JD, Aykin-Burns N, Spitz DR, Gius D, Kim HS. 2011. Sirt3, mitochondrial ROS, ageing, and carcinogenesis. Int. J. Mol. Sci. 12:6226–6239. http://dx.doi.org/10.3390/ijms12096226.
   PubMed Web of Science ®Google Scholar
• Ahn BH, Kim HS, Song S, Lee IH, Liu J, Vassilopoulos A, Deng CX, Finkel T. 2008. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl. Acad. Sci. U. S. A. 105:14447–14452. http://dx.doi.org/10.1073/pnas.0803790105.
   PubMed Web of Science ®Google Scholar
• Cimen H, Han MJ, Yang Y, Tong Q, Koc H, Koc EC. 2010. Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria. Biochemistry 49:304–311. http://dx.doi.org/10.1021/bi901627u.
   PubMed Web of Science ®Google Scholar
• Zanna C, Ghelli A, Porcelli AM, Karbowski M, Youle RJ, Schimpf S, Wissinger B, Pinti M, Cossarizza A, Vidoni S, Valentino ML, Rugolo M, Carelli V. 2008. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion. Brain 131:352–367. http://dx.doi.org/10.1093/brain/awm335.
   PubMed Web of Science ®Google Scholar
• Balaban RS, Nemoto S, Finkel T. 2005. Mitochondria, oxidants, and aging. Cell 120:483–495. http://dx.doi.org/10.1016/j.cell.2005.02.001.
   PubMed Web of Science ®Google Scholar
• Brand MD, Buckingham JA, Esteves TC, Green K, Lambert AJ, Miwa S, Murphy MP, Pakay JL, Talbot DA, Echtay KS. 2004. Mitochondrial superoxide and aging: uncoupling-protein activity and superoxide production. Biochem. Soc. Symp. 71:203–213. http://symposia.biochemistry.org/bssymp/071/bss0710203.htm.
   PubMedGoogle Scholar
• Leruez S, Milea D, Defoort-Dhellemmes S, Colin E, Crochet M, Procaccio V, Ferre M, Lamblin J, Drouin V, Vincent-Delorme C, Lenaers G, Hamel C, Blanchet C, Juul G, Larsen M, Verny C, Reynier P, Amati-Bonneau P, Bonneau D. 2013. Sensorineural hearing loss in OPA1-linked disorders. Brain 136:e236. http://dx.doi.org/10.1093/brain/aws340.
   PubMedGoogle Scholar
• Yang H, Yang T, Baur JA, Perez E, Matsui T, Carmona JJ, Lamming DW, Souza-Pinto NC, Bohr VA, Rosenzweig A, de Cabo R, Sauve AA, Sinclair DA. 2007. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell 130:1095–1107. http://dx.doi.org/10.1016/j.cell.2007.07.035.
   PubMed Web of Science ®Google Scholar
• Scorrano L, Ashiya M, Buttle K, Weiler S, Oakes SA, Mannella CA, Korsmeyer SJ. 2002. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev. Cell 2:55–67. http://dx.doi.org/10.1016/S1534-5807(01)00116-2.
   PubMed Web of Science ®Google Scholar
• Suen DF, Norris KL, Youle RJ. 2008. Mitochondrial dynamics and apoptosis. Genes Dev. 22:1577–1590. http://dx.doi.org/10.1101/gad.1658508.
   PubMed Web of Science ®Google Scholar
• Arnoult D, Grodet A, Lee YJ, Estaquier J, Blackstone C. 2005. Release of OPA1 during apoptosis participates in the rapid and complete release of cytochrome c and subsequent mitochondrial fragmentation. J. Biol. Chem. 280:35742–35750. http://dx.doi.org/10.1074/jbc.M505970200.
   PubMedGoogle Scholar
• Olichon A, Landes T, Arnaune-Pelloquin L, Emorine LJ, Mils V, Guichet A, Delettre C, Hamel C, Amati-Bonneau P, Bonneau D, Reynier P, Lenaers G, Belenguer P. 2007. Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis. J. Cell Physiol. 211:423–430. http://dx.doi.org/10.1002/jcp.20950.
   PubMed Web of Science ®Google Scholar
• Abel ED, Doenst T. 2011. Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy. Cardiovasc. Res. 90:234–242. http://dx.doi.org/10.1093/cvr/cvr015.
   PubMed Web of Science ®Google Scholar
• Dai DF, Johnson SC, Villarin JJ, Chin MT, Nieves-Cintron M, Chen T, Marcinek DJ, Dorn GWII, Kang YJ, Prolla TA, Santana LF, Rabinovitch PS. 2011. Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ. Res. 108:837–846. http://dx.doi.org/10.1161/CIRCRESAHA.110.232306.
   PubMed Web of Science ®Google Scholar
• Sack MN. 2009. Type 2 diabetes, mitochondrial biology and the heart. J. Mol. Cell Cardiol. 46:842–849. http://dx.doi.org/10.1016/j.yjmcc.2009.02.001.
   PubMedGoogle Scholar
• Keller MP, Choi Y, Wang P, Davis DB, Rabaglia ME, Oler AT, Stapleton DS, Argmann C, Schueler KL, Edwards S, Steinberg HA, Chaibub Neto E, Kleinhanz R, Turner S, Hellerstein MK, Schadt EE, Yandell BS, Kendziorski C, Attie AD. 2008. A gene expression network model of type 2 diabetes links cell cycle regulation in islets with diabetes susceptibility. Genome Res. 18:706–716. http://dx.doi.org/10.1101/gr.074914.107.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wakabayashi N, Wakabayashi J, Tamura Y, Song WJ, Sereda S, Clerc P, Polster BM, Aja SM, Pletnikov MV, Kensler TW, Shirihai OS, Iijima M, Hussain MA, Sesaki H. 2011. The dynamin-related GTPase Opa1 is required for glucose-stimulated ATP production in pancreatic beta cells. Mol. Biol. Cell 22:2235–2245. http://dx.doi.org/10.1091/mbc.E10-12-0933.
   PubMed Web of Science ®Google Scholar
• Makino A, Suarez J, Gawlowski T, Han W, Wang H, Scott BT, Dillmann WH. 2011. Regulation of mitochondrial morphology and function by O-GlcNAcylation in neonatal cardiac myocytes. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300:R1296–R1302. http://dx.doi.org/10.1152/ajpregu.00437.2010.
   PubMed Web of Science ®Google Scholar
• Cipolat S, Rudka T, Hartmann D, Costa V, Serneels L, Craessaerts K, Metzger K, Frezza C, Annaert W, D'Adamio L, Derks C, Dejaegere T, Pellegrini L, D'Hooge R, Scorrano L, De Strooper B. 2006. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell 126:163–175. http://dx.doi.org/10.1016/j.cell.2006.06.021.
   PubMed Web of Science ®Google Scholar
• Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, Pelloquin L, Grosgeorge J, Turc-Carel C, Perret E, Astarie-Dequeker C, Lasquellec L, Arnaud B, Ducommun B, Kaplan J, Hamel CP. 2000. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat. Genet. 26:207–210. http://dx.doi.org/10.1038/79936.
   PubMed Web of Science ®Google Scholar
• Ishihara N, Fujita Y, Oka T, Mihara K. 2006. Regulation of mitochondrial morphology through proteolytic cleavage of OPA1. EMBO J. 25:2966–2977. http://dx.doi.org/10.1038/sj.emboj.7601184.
   PubMed Web of Science ®Google Scholar
• Nochez Y, Arsene S, Gueguen N, Chevrollier A, Ferre M, Guillet V, Desquiret V, Toutain A, Bonneau D, Procaccio V, Amati-Bonneau P, Pisella PJ, Reynier P. 2009. Acute and late-onset optic atrophy due to a novel OPA1 mutation leading to a mitochondrial coupling defect. Mol. Vis. 15:598–608.
   PubMed Web of Science ®Google Scholar
• Zhu PP, Patterson A, Stadler J, Seeburg DP, Sheng M, Blackstone C. 2004. Intra- and intermolecular domain interactions of the C-terminal GTPase effector domain of the multimeric dynamin-like GTPase Drp1. J. Biol. Chem. 279:35967–35974. http://dx.doi.org/10.1074/jbc.M404105200.
   PubMedGoogle Scholar